Hydrogel eye drop carrier containing polymer micelle and preparation method of hydrogel eye drop carrier
A polymer glue and polymer technology, which can be used in pharmaceutical formulations, medical preparations with non-active ingredients, and non-active ingredients of polymer compounds. The effect of oxygen permeability, great social benefit and economic benefit
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0062] Example 1
[0063] Dissolve 57.6mg β-CD in 10ml ultrapure water, then add 10ml 0.72% W / V PAA (number average molecular weight 100,000, the same below) aqueous solution and 10ml 0.44% W / V PEG (number average molecular weight 6000, below Same) Aqueous solution. The resulting mixture was stirred at room temperature for 24 hours and then allowed to stand overnight. The solution containing polymer micelles was dialyzed against a dialysis bag with a molecular weight cut-off of 3000 for 3 days, and the water was changed every 4 hours to remove free β-CD in the mixed solution to obtain a polymer micelle solution. The light transmittance of polymer micelles is greater than 90%, such as figure 1 M-0.1-50. The particle size is 64nm, the zeta potential is -20.1±0.8, the loading of ofloxacin in the polymer micelle is 3.26μg / ml, and the loading of puerarin in the polymer micelle is 6.17μg / ml. HEMA monomer (the volume ratio of water in the total system is 2:1) and 2wt% MPC monomer (0...
Example Embodiment
[0064] Example 2
[0065] Dissolve 5.8 mg of β-CD in 10 ml of ultrapure water, and then add 10 ml of 0.072% W / V PAA aqueous solution and 10 ml of 0.044% W / V PEG aqueous solution. The resulting mixture was stirred at room temperature for 24 hours and then allowed to stand overnight. The solution containing polymer micelles was dialyzed against a dialysis bag with a molecular weight cut-off of 3000 for 3 days, and the water was changed every 4 hours to remove free β-CD in the mixed solution to obtain a polymer micelle solution. The light transmittance of polymer micelles is greater than 95%, such as figure 1 M-0.01-50. The particle size is 39nm, the zeta potential is -29.7±0.9, and the loading of puerarin in the polymer micelles is 1.15μg / ml. HEMA monomer (the volume ratio of water in the total system is 2:1) and 2% MPC monomer (0.5% of the total mass of micellar liquid and monomer) are mixed, and then 35% polymer micelle aqueous solution (by mixing After the total mass of the ...
Example Embodiment
[0066] Example 3
[0067] Dissolve 28.8 mg of β-CD in 10 ml of ultrapure water, and then add 10 ml of 0.36% W / V PAA aqueous solution and 10 ml of 0.22% W / V PEG aqueous solution. The resulting mixture was stirred at room temperature for 24 hours and then allowed to stand overnight. The solution containing polymer micelles was dialyzed against a dialysis bag with a molecular weight cut-off of 3000 for 3 days, and the water was changed every 4 hours to remove free β-CD in the mixed solution to obtain a polymer micelle solution. The light transmittance of polymer micelles is greater than 95%, such as figure 1 The M-0.05-50. The particle size is 53nm, the zeta potential is -23.3±0.9, the loading of ofloxacin in polymer micelles is 1.94μg / ml, and the loading of puerarin in polymer micelles is 3.85μg / ml. HEMA monomer (the volume ratio of water in the total system is 2:1) and 2% MPC monomer (0.5% of the total mass of micellar liquid and monomer) are mixed, and then 35% polymer micelle...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap